Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients/Experiment 1

From BugSigDB


Needs review

Curated date: 2024/03/26

Curator: PraiseAgbetuyi

Revision editor(s): PraiseAgbetuyi, KwennB

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Psoriasis Other and unspecified pityriasis,OTHER PSORIASIS,Other psoriasis and similar disorders,Other psoriasis and similar disorders (disorder),Other psoriasis and similar disorders excluding psoriatic arthropathy,Palmoplantaris Pustulosis,PITYRIASIS NEC & NOS,PSORIAS RELATED DIS NEC,Psoriases,psoriasis,Psoriasis and similar disorders,Psoriasis and similar disorders (disorder),Psoriasis and similar disorders (navigational concept),Psoriasis and similar disorders NOS,Psoriasis and similar disorders NOS (disorder),Pustular Psoriasis of Palms and Soles,PUSTULAR PSORIASIS OF PALMS SOLES,Pustulosis of Palms and Soles,PUSTULOSIS OF PALMS SOLES,Pustulosis Palmaris et Plantaris,Psoriasis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control (HC)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Psoriasis
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with psoriasis
Group 0 sample size Number of subjects in the control (unexposed) group
30
Group 1 sample size Number of subjects in the case (exposed) group
30
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Within a month before the start of the study

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V5
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.00

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2024/03/28

Curator: PraiseAgbetuyi

Revision editor(s): PraiseAgbetuyi

Source: Figure 2 e/f

Description: Differentially abundant taxa between the psoriasis group (P) and healthy control group (N) which was generated from LEfSe analysis

Abundance in Group 1: increased abundance in Psoriasis

NCBI Quality ControlLinks
Faecalibacterium
Gemmiger
Megamonas
Pyramidobacter
Synergistales
Synergistes
Synergistia
Veillonellaceae
Dethiosulfovibrionaceae

Revision editor(s): PraiseAgbetuyi

Signature 2

Needs review

Curated date: 2024/03/28

Curator: PraiseAgbetuyi

Revision editor(s): PraiseAgbetuyi

Source: Figure 2 e/f

Description: Differentially abundant taxa between the psoriasis group (P) and healthy control group (N) which was generated from LEfSe analysis

Abundance in Group 1: decreased abundance in Psoriasis

NCBI Quality ControlLinks
Fusobacterium
Fusobacteriaceae
Bacteroidaceae
Bacteroides

Revision editor(s): PraiseAgbetuyi